PragmaClin

PragmaClin operates at the intersection of digital health, medical devices, neuroscience, and clinical assessment. Its PRIMS® platform uses 3D depth cameras to support remote motor evaluations and reporting, with assessments aligned to MDS-UPDRS scales. That focus differentiates its described offering from general-purpose telehealth software: the product is oriented toward capturing and standardizing neurological motor symptoms rather than simply enabling remote consultations. The platform is also described as supporting clinicians, researchers, and people with Parkinson’s through a separate patient portal for viewing results and completing symptom surveys. The broader competitive landscape includes digital neurology assessment and remote-monitoring products, but specific relative performance, clinical adoption, regulatory clearance, and commercial scale are not established here. PragmaClin’s listed categories include AI, medical devices, health care, and neuroscience; its recorded support includes grants and pre-seed funding rather than a disclosed large institutional equity round. These signals suggest a specialized early-stage position, with differentiation tied to camera-based measurement and neurological assessment workflows.

PragmaClin was founded in 2020 and has a recorded employee-size band of 1–10. A separate hiring signal says the team grew from two full-time members to more than 12 during the year preceding May 2023, so the reported headcount and employee-size band may reflect different dates or definitions. The company’s funding history shows a sequence of grant, pre-seed, and non-equity support, with the latest listed grant dated Jan 1, 2025. Notable recorded milestones include a USD 50,000 pre-seed round in April 2023, a USD 100,000 Ontario Brain Institute grant in September 2023, a CAD 150,000 pre-seed round recorded as USD 113,256 in January 2024, and a CAD 50,000 grant recorded as USD 34,782 in January 2025. Product development centers on PRIMS® and its patient portal, extending the system from clinician-facing assessment toward remote access to results and symptom surveys.